Cybin Inc (CYBN): Price to Sales

Cybin Inc. (CYBN) operates on external investments due to a lack of sales and negative cash flow. The company's P/S ratio visualizes the market valuation of the asset, where the mark serves as the current indicator. The developer is creating a comprehensive psychiatric care system by introducing innovative molecules. The reliability of substance supplies is ensured through strict audits of logistics chains and the diversification of laboratories.

For Cybin Inc. (CYBN), evaluating market value relative to annual turnover allows for the determination of the business premium, taking into account costs for specialized logistics and drug delivery audits. By analyzing the P/S multiple trend, an investor can observe the ratio of market capitalization to revenue, which helps identify points of asset overheating or potential undervaluation within the context of the company's operational efficiency.